IMMUNE PREVENTION OF RESPIRATORY-SYNCYTIAL VIRAL INFECTION: 15 YEARS OF WORLD EXPERIENCE

IMMUNE PREVENTION OF RESPIRATORY-SYNCYTIAL VIRAL INFECTION: 15 YEARS OF WORLD EXPERIENCE

The article is dedicated to one of the most important issues of modern neonatology – prevention of respiratory-syncytial virus infection, which is a frequent cause of bronchiolites and pneumoniae in infants and neonates, especially premature infants. The latter belong to the high-risk group for the...

Full description

Saved in:

Bibliographic Details
Main Author:	E. S. Keshishyan
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2013-07-01
Series:	Педиатрическая фармакология
Subjects:	respiratory-syncytial virus infection epidemiology morbidity consequences risk groups prevention palivizumab efficacy safety children neonates premature infants
Online Access:	https://www.pedpharma.ru/jour/article/view/191
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Respiratory syncytial virus immunization patterns in Germany, 2015–2020
by: Moritz Wick, et al.
Published: (2024-12-01)

Immunoprophylaxis of Respiratory Syncytial Virus Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants
by: Andreea Calomfirescu-Avramescu, et al.
Published: (2025-02-01)

Cost-effectiveness of nirsevimab and palivizumab for respiratory syncytial virus prophylaxis in preterm infants 29–34 6/7 weeks' gestation in the United States
by: Tianzhou Yu, et al.
Published: (2024-03-01)

Palivizumab for the Prophylaxis of Respiratory Syncytial Virus Disease: Expert Opinion and Recommendations for the Gulf Cooperation Council Region
by: Adel S. Alharbi, et al.
Published: (2024-09-01)

Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant
by: Teresa Jackowska, et al.
Published: (2024-12-01)

Effectiveness of palivizumab immunoprophylaxis in infants with respiratory syncytial virus disease in Colombia
by: Juan Gabriel Piñeros, et al.
Published: (2021-11-01)

Cost effectiveness of a protocol using palivizumab in preterm infants
by: Yolanda Hernández-Gago, et al.
Published: (2017-03-01)

IMMUNOPTOPHYLAXIS OF THE RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN UNDER RISK OF HEAVY COURSE OF THE DISEASE: PRELIMINARY RESULTS OF IMPLEMENTING THE MOSCOW PROGRAM
by: A. A. Korsunskiy, et al.
Published: (2012-06-01)

IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS
by: A. A. Baranov, et al.
Published: (2012-12-01)

Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
by: Envera Lekic, et al.
Published: (2024-05-01)

Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]
by: Mark D. Lyttle, et al.
Published: (2024-12-01)

A CLINICAL AND ECONOMICAL ANALYSIS OF THE RESULTS PRODUCED BY THE PROGRAM OF RSV-INFECTION PROPHYLAXIS DURING THE EPIDEMIOLOGICAL SEASON OF 2012/2013 IN MOSCOW
by: V. I. Ignat'eva, et al.
Published: (2013-11-01)

Respiratory syncytial virus immunization in children: The old, the new and what’s just around the corner
by: Bosco A. Paes, et al.
Published: (2025-12-01)

Effect of an In-Home Palivizumab Administration Program for Children with Medical Complexity
by: Hina Emanuel, et al.
Published: (2024-09-01)

Burden of respiratory syncytial virus disease in infants and the potential value of maternal immunization in Greece
by: George Gourzoulidis, et al.
Published: (2025-07-01)

Prospective hospital-based cohort studies of Respiratory Syncytial Virus (RSV) infections in infants under one year during and after the SARS-CoV-2 pandemic in Japan
by: Koo Nagasawa, et al.
Published: (2024-12-01)

Improving the quality of care of respiratory syncytial virus in the neonatal and pediatric populations globally
by: Fungwe Jah, et al.
Published: (2025-05-01)

Epidemiological and Clinical Characteristics of Respiratory Syncytial Virus Infection in Children in Hangzhou (2022–2023)
by: Qin-Rui Lai, et al.
Published: (2025-06-01)

Modern Approaches in management of Children with Acute Bronchiolitis
by: Alexander A. Baranov, et al.
Published: (2020-02-01)

Respiratory Syncytial Virus Infection. Pathogenesis Peculiarities, Prevention and Treatment Strategies
by: V. Z. Krivitskaya
Published: (2013-03-01)

Respiratory Syncytial Virus Lower Respiratory Tract Infections in Premature Infants and Infants with Bronchopulmonary Dysplasia
by: D. Yu. Ovsyannikov, et al.
Published: (2015-10-01)

THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS
by: A. V. Rudakova, et al.
Published: (2012-07-01)

Respiratory syncytial viral infection in children. Role in the structure of respiratory pathology and clinical and immunological features
by: V. V. Sokolovskaya, et al.
Published: (2020-03-01)

Description of respiratory syncytial virus genotypes circulating in Colombia
by: Viviana Avila, et al.
Published: (2018-12-01)

The Epidemiology of Respiratory Syncytial Virus and the Impact of the COVID-19 Pandemic in a Retrospective Evaluation
by: Paolo Solidoro, et al.
Published: (2025-04-01)

Epidemiology and genetic diversity of human respiratory syncytial virus in Belgium between 2011 and 2019
by: Kaat Ramaekers, et al.
Published: (2024-10-01)

Long-Term Trends in Respiratory Syncytial Virus A Infections (2007–2024) in Korea
by: Jeong Su Han, et al.
Published: (2025-05-01)

Impact of the COVID-19 pandemic on the seasonality of respiratory syncytial viral infection
by: I. V. Babachenko, et al.
Published: (2022-07-01)

Evolutionary trajectory and spread of respiratory syncytial virus group A in neonatal cohorts in Pakistan amidst the COVID-19 pandemic
by: Sana Tamim, et al.
Published: (2025-07-01)

The Impact of Palivizumab for Respiratory Syncytial Virus Prophylaxis on Preschool Childhood Asthma
by: Hannah Ora Hasson, et al.
Published: (2024-11-01)

Genotypic Characterization of Human Respiratory Syncytial Viruses Detected in Mexico Between 2021 and 2024
by: Nadia Martínez-Marrero, et al.
Published: (2025-04-01)

Immunoprophylaxis of infectious diseases in premature infants
by: Alexander A. Baranov, et al.
Published: (2018-12-01)

Molecular epidemiology of influenza, respiratory syncytial virus, SARS-CoV-2, other respiratory viruses and bacteria among children 0–2-year-olds in West Bengal: a one-year influenza-like illness surveillance study (2022–2023)
by: Tila Khan, et al.
Published: (2025-05-01)

Potential public health and economic impact of maternal vaccination with bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine for the prevention of acute respiratory infection among infants in the United States
by: Ahuva Averin, et al.
Published: (2025-12-01)

A Review of Recent Cluster of Hospitalization-related Respiratory Syncytial Virus Infection Post-COVID-19: A Cross-sectional Study
by: Khalid Al Dhuhli, et al.
Published: (2024-01-01)

Respiratory Syncytial Virus (RSV) Hospitalization Seasonal Patterns and Economic Burden in the US: Implications for Further Optimizing the Use of RSV Preventives
by: Amy W. Law, et al.
Published: (2025-03-01)

An overview of respiratory syncytial virus infections in Saudi Arabia
by: Anwar Ahmed, et al.
Published: (2018-11-01)

Knowledge and Attitudes Regarding Respiratory Syncytial Virus (RSV) Prevention: A Systematic Review
by: Teresa Gavaruzzi, et al.
Published: (2025-02-01)

Clinical and epidemiological characteristics of respiratory syncytial virus, SARS-CoV-2 and influenza paediatric viral respiratory infections in southwest Saudi Arabia
by: Ali Alsuheel Asseri, et al.
Published: (2025-12-01)